Nivedita Shetty works for the Small Molecule Pharmaceutical Sciences Department of Genentech, Inc., in South San Francisco, CA responsible for formulation development of inhaled and oral drugs to support phase I clinical studies.
Prior to joining Genentech, she completed her PhD in Pharmaceutics at Purdue University with a focus in particle engineering for inhalation. During her PhD she was awarded the Outstanding Student Research Award from National Institute for Pharmaceutical Technology & Education (NIPTE); Excipient Graduate Student Scholarship by International Pharmaceutical Excipients Council (IPEC); McKeehan Graduate Fellowship and Ronald W. Dollens Graduate Scholarship from Purdue University. She holds undergraduate Pharmacy degree from Bombay College of Pharmacy, India and Master’s degrees in Pharmaceutics from Northeastern University, Boston.
She served as co-chair for New Devices and Emerging Therapies networking group at International Society for Aerosol in Medicine (ISAM) and current secretary of Inhalation and Nasal Community of American Association of Pharmaceutical Scientists (AAPS). She serves as an expert reviewer on numerous journals including AAPS PharmSciTech, Molecular Pharmaceutics and Pharmaceutics (MDPI).
Her current research interests are particle engineering for high drug load inhaled formulation and mechanistic understanding of the role of material properties on aerosol performance.

